 Denis Bensard
Concepts (550)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds, Nonpenetrating | 34 | 2022 | 283 | 7.750 |
Why?
| | Wounds and Injuries | 22 | 2023 | 719 | 4.980 |
Why?
| | Trauma Centers | 39 | 2023 | 410 | 4.480 |
Why?
| | Shock | 8 | 2022 | 95 | 3.780 |
Why?
| | Injury Severity Score | 44 | 2023 | 518 | 3.760 |
Why?
| | Abdominal Injuries | 13 | 2022 | 122 | 3.080 |
Why?
| | Blood Transfusion | 17 | 2022 | 293 | 3.010 |
Why?
| | Shock, Hemorrhagic | 6 | 2021 | 165 | 2.390 |
Why?
| | Glasgow Coma Scale | 8 | 2023 | 170 | 2.210 |
Why?
| | Wounds, Penetrating | 4 | 2023 | 66 | 1.920 |
Why?
| | Spleen | 7 | 2021 | 513 | 1.690 |
Why?
| | Craniocerebral Trauma | 6 | 2022 | 154 | 1.680 |
Why?
| | Triage | 8 | 2022 | 213 | 1.640 |
Why?
| | Child | 98 | 2023 | 20805 | 1.620 |
Why?
| | Brain Injuries | 9 | 2015 | 468 | 1.610 |
Why?
| | Retrospective Studies | 71 | 2023 | 14571 | 1.560 |
Why?
| | Blood Coagulation Disorders | 5 | 2022 | 162 | 1.540 |
Why?
| | Thoracic Injuries | 4 | 2018 | 56 | 1.480 |
Why?
| | Thoracotomy | 8 | 2020 | 74 | 1.450 |
Why?
| | Blood Component Transfusion | 3 | 2022 | 79 | 1.350 |
Why?
| | Child, Preschool | 60 | 2023 | 10450 | 1.260 |
Why?
| | Thrombelastography | 5 | 2022 | 148 | 1.190 |
Why?
| | Tomography, X-Ray Computed | 15 | 2022 | 2541 | 1.180 |
Why?
| | Liver | 9 | 2021 | 1833 | 1.170 |
Why?
| | Laparoscopy | 11 | 2015 | 454 | 1.130 |
Why?
| | Adolescent | 64 | 2023 | 20301 | 1.050 |
Why?
| | Appendicitis | 7 | 2021 | 132 | 1.030 |
Why?
| | Resuscitation | 5 | 2022 | 240 | 1.010 |
Why?
| | Emergency Service, Hospital | 8 | 2023 | 1973 | 1.000 |
Why?
| | Appendectomy | 6 | 2021 | 83 | 0.980 |
Why?
| | Hematocrit | 2 | 2015 | 94 | 0.920 |
Why?
| | Infant | 46 | 2023 | 8992 | 0.910 |
Why?
| | Erythrocyte Transfusion | 3 | 2022 | 182 | 0.850 |
Why?
| | Emergency Medical Services | 3 | 2023 | 550 | 0.850 |
Why?
| | Decision Support Techniques | 4 | 2022 | 405 | 0.830 |
Why?
| | Humans | 134 | 2023 | 129116 | 0.820 |
Why?
| | Child Abuse | 6 | 2014 | 518 | 0.810 |
Why?
| | Severity of Illness Index | 4 | 2019 | 2739 | 0.800 |
Why?
| | Length of Stay | 13 | 2022 | 1123 | 0.800 |
Why?
| | Heart Rate | 6 | 2023 | 808 | 0.790 |
Why?
| | Male | 98 | 2022 | 63194 | 0.750 |
Why?
| | Risk Adjustment | 1 | 2022 | 79 | 0.740 |
Why?
| | Early Medical Intervention | 1 | 2022 | 58 | 0.740 |
Why?
| | Blood Pressure | 7 | 2023 | 1735 | 0.710 |
Why?
| | Radiation Exposure | 1 | 2020 | 45 | 0.670 |
Why?
| | Intubation, Gastrointestinal | 3 | 2020 | 75 | 0.660 |
Why?
| | Female | 76 | 2022 | 68510 | 0.640 |
Why?
| | Patient Selection | 2 | 2022 | 665 | 0.630 |
Why?
| | Hypotension | 3 | 2016 | 114 | 0.630 |
Why?
| | Enteral Nutrition | 2 | 2020 | 184 | 0.620 |
Why?
| | Catheterization, Central Venous | 2 | 2018 | 97 | 0.610 |
Why?
| | Pylorus | 2 | 2010 | 18 | 0.600 |
Why?
| | Pyloric Stenosis, Hypertrophic | 2 | 2010 | 11 | 0.600 |
Why?
| | Lung Diseases | 7 | 2022 | 723 | 0.580 |
Why?
| | Hospitals, Pediatric | 4 | 2018 | 517 | 0.580 |
Why?
| | Colorado | 25 | 2022 | 4394 | 0.570 |
Why?
| | Brain Injuries, Traumatic | 1 | 2021 | 340 | 0.530 |
Why?
| | Bacteremia | 1 | 2018 | 194 | 0.530 |
Why?
| | Head Injuries, Closed | 3 | 2012 | 50 | 0.520 |
Why?
| | Hemoglobins | 3 | 2022 | 337 | 0.510 |
Why?
| | Bicycling | 1 | 2017 | 118 | 0.510 |
Why?
| | Gastrostomy | 2 | 2015 | 112 | 0.510 |
Why?
| | Upper Gastrointestinal Tract | 1 | 2015 | 5 | 0.500 |
Why?
| | Intestinal Volvulus | 1 | 2015 | 14 | 0.500 |
Why?
| | Thrombosis | 1 | 2018 | 323 | 0.480 |
Why?
| | Lung | 14 | 2022 | 3752 | 0.480 |
Why?
| | Rehydration Solutions | 1 | 2014 | 8 | 0.470 |
Why?
| | Isotonic Solutions | 1 | 2014 | 37 | 0.470 |
Why?
| | Shock, Traumatic | 1 | 2014 | 14 | 0.460 |
Why?
| | Infant, Newborn | 17 | 2020 | 5739 | 0.450 |
Why?
| | Preoperative Care | 2 | 2015 | 342 | 0.450 |
Why?
| | Multiple Trauma | 7 | 2014 | 103 | 0.440 |
Why?
| | Vascular System Injuries | 3 | 2021 | 73 | 0.420 |
Why?
| | Gastroesophageal Reflux | 1 | 2015 | 232 | 0.410 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2013 | 71 | 0.410 |
Why?
| | Critical Illness | 1 | 2018 | 736 | 0.410 |
Why?
| | Acidosis | 1 | 2013 | 88 | 0.400 |
Why?
| | Laparotomy | 7 | 2023 | 109 | 0.400 |
Why?
| | Referral and Consultation | 1 | 2018 | 732 | 0.400 |
Why?
| | Risk Assessment | 4 | 2021 | 3260 | 0.400 |
Why?
| | Tracheostomy | 1 | 2014 | 119 | 0.400 |
Why?
| | Sensitivity and Specificity | 6 | 2022 | 1825 | 0.390 |
Why?
| | Risk Factors | 14 | 2022 | 9767 | 0.390 |
Why?
| | Age Factors | 8 | 2021 | 3120 | 0.390 |
Why?
| | Registries | 11 | 2021 | 1884 | 0.380 |
Why?
| | Prognosis | 10 | 2023 | 3788 | 0.380 |
Why?
| | Spinal Cord Injuries | 2 | 2014 | 193 | 0.360 |
Why?
| | Treatment Outcome | 18 | 2020 | 10226 | 0.340 |
Why?
| | Mass Screening | 2 | 2019 | 1159 | 0.320 |
Why?
| | Critical Pathways | 1 | 2009 | 80 | 0.290 |
Why?
| | Viscera | 2 | 2005 | 16 | 0.290 |
Why?
| | Wounds, Gunshot | 2 | 2022 | 217 | 0.290 |
Why?
| | Lipopolysaccharides | 10 | 2004 | 856 | 0.280 |
Why?
| | Thoracoscopy | 4 | 2006 | 51 | 0.280 |
Why?
| | Adult | 30 | 2022 | 35510 | 0.270 |
Why?
| | Accidents, Home | 2 | 2004 | 29 | 0.260 |
Why?
| | Endotoxins | 7 | 1999 | 216 | 0.260 |
Why?
| | Pyelonephritis, Xanthogranulomatous | 1 | 2006 | 2 | 0.260 |
Why?
| | Radiation Dosage | 2 | 2020 | 153 | 0.250 |
Why?
| | Survival Rate | 8 | 2016 | 1875 | 0.250 |
Why?
| | Heart Arrest | 3 | 2018 | 328 | 0.250 |
Why?
| | Follow-Up Studies | 9 | 2022 | 4915 | 0.230 |
Why?
| | Digestive System Surgical Procedures | 1 | 2005 | 99 | 0.230 |
Why?
| | Surgeons | 2 | 2021 | 277 | 0.230 |
Why?
| | Receptors, Adrenergic, beta | 3 | 1994 | 126 | 0.230 |
Why?
| | Leg Injuries | 1 | 2004 | 28 | 0.220 |
Why?
| | Neutrophils | 13 | 2002 | 1195 | 0.220 |
Why?
| | Incidence | 11 | 2020 | 2635 | 0.220 |
Why?
| | Surgical Wound | 1 | 2023 | 20 | 0.210 |
Why?
| | Anticoagulants | 3 | 2019 | 614 | 0.210 |
Why?
| | Intestines | 2 | 2004 | 349 | 0.200 |
Why?
| | Precipitating Factors | 1 | 2022 | 4 | 0.200 |
Why?
| | Pediatric Emergency Medicine | 1 | 2022 | 19 | 0.190 |
Why?
| | Enterocolitis, Neutropenic | 1 | 2021 | 6 | 0.190 |
Why?
| | False Positive Reactions | 1 | 2022 | 114 | 0.190 |
Why?
| | Intracranial Pressure | 1 | 2022 | 46 | 0.190 |
Why?
| | Heart Injuries | 1 | 2021 | 36 | 0.190 |
Why?
| | Fundoplication | 2 | 2015 | 54 | 0.180 |
Why?
| | Hypovolemia | 1 | 2021 | 10 | 0.180 |
Why?
| | Logistic Models | 3 | 2016 | 1979 | 0.180 |
Why?
| | Intraoperative Complications | 1 | 2022 | 132 | 0.180 |
Why?
| | Time Factors | 10 | 2014 | 6518 | 0.180 |
Why?
| | Jejunostomy | 1 | 2020 | 12 | 0.180 |
Why?
| | Early Diagnosis | 1 | 2022 | 236 | 0.170 |
Why?
| | Frailty | 1 | 2023 | 150 | 0.170 |
Why?
| | Postoperative Care | 3 | 2019 | 243 | 0.170 |
Why?
| | Prospective Studies | 7 | 2022 | 7079 | 0.170 |
Why?
| | Plasma | 1 | 2022 | 201 | 0.170 |
Why?
| | Stomach | 1 | 2020 | 109 | 0.170 |
Why?
| | Respiration, Artificial | 3 | 2014 | 601 | 0.170 |
Why?
| | Hospital Mortality | 2 | 2014 | 844 | 0.170 |
Why?
| | Cerebrovascular Trauma | 1 | 2019 | 16 | 0.160 |
Why?
| | Mortality | 1 | 2022 | 308 | 0.160 |
Why?
| | Salmonella typhimurium | 6 | 2002 | 176 | 0.160 |
Why?
| | Phlebotomy | 1 | 2019 | 17 | 0.160 |
Why?
| | Heart | 2 | 1994 | 639 | 0.160 |
Why?
| | Monitoring, Physiologic | 1 | 2021 | 268 | 0.160 |
Why?
| | Firearms | 2 | 2022 | 361 | 0.150 |
Why?
| | Diagnosis, Differential | 5 | 2014 | 1417 | 0.150 |
Why?
| | Central Venous Catheters | 1 | 2018 | 48 | 0.150 |
Why?
| | Isoproterenol | 4 | 1998 | 107 | 0.150 |
Why?
| | Platelet Activating Factor | 3 | 1992 | 74 | 0.150 |
Why?
| | Feasibility Studies | 1 | 2022 | 862 | 0.150 |
Why?
| | Trauma Severity Indices | 4 | 2013 | 106 | 0.150 |
Why?
| | Cholestasis | 1 | 2000 | 230 | 0.140 |
Why?
| | Stroke | 2 | 2019 | 1067 | 0.140 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 963 | 0.140 |
Why?
| | Hospitalization | 4 | 2016 | 2077 | 0.140 |
Why?
| | Colforsin | 4 | 2001 | 50 | 0.140 |
Why?
| | Abdomen, Acute | 1 | 1997 | 18 | 0.140 |
Why?
| | Algorithms | 2 | 2021 | 1621 | 0.140 |
Why?
| | Patient Readmission | 2 | 2020 | 668 | 0.140 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2015 | 261 | 0.140 |
Why?
| | Health Care Costs | 1 | 2020 | 395 | 0.140 |
Why?
| | Immune System Diseases | 1 | 1997 | 35 | 0.140 |
Why?
| | United States | 7 | 2022 | 13938 | 0.140 |
Why?
| | Reproducibility of Results | 2 | 2015 | 3033 | 0.130 |
Why?
| | Hospital Charges | 1 | 2016 | 41 | 0.130 |
Why?
| | Intensive Care Units | 1 | 2022 | 719 | 0.130 |
Why?
| | Surgery Department, Hospital | 1 | 2016 | 22 | 0.130 |
Why?
| | Hospital Rapid Response Team | 1 | 2016 | 18 | 0.130 |
Why?
| | Myocardial Reperfusion Injury | 4 | 1992 | 121 | 0.130 |
Why?
| | Cause of Death | 2 | 2014 | 393 | 0.130 |
Why?
| | Multiple Organ Failure | 4 | 2003 | 121 | 0.130 |
Why?
| | Chemokines | 3 | 2001 | 222 | 0.130 |
Why?
| | Hemostatic Techniques | 1 | 2016 | 45 | 0.130 |
Why?
| | Exsanguination | 2 | 2012 | 19 | 0.130 |
Why?
| | Medical Futility | 1 | 2015 | 24 | 0.120 |
Why?
| | Funnel Chest | 2 | 2005 | 21 | 0.120 |
Why?
| | Splenectomy | 1 | 2015 | 58 | 0.120 |
Why?
| | Research Design | 1 | 2022 | 1040 | 0.120 |
Why?
| | Intestine, Small | 1 | 1996 | 144 | 0.120 |
Why?
| | Critical Care | 3 | 2013 | 544 | 0.120 |
Why?
| | Arterial Occlusive Diseases | 1 | 1995 | 79 | 0.120 |
Why?
| | Specialization | 1 | 2016 | 144 | 0.120 |
Why?
| | Ultrasonography | 4 | 2010 | 724 | 0.120 |
Why?
| | Benchmarking | 1 | 2016 | 176 | 0.120 |
Why?
| | Hemorrhage | 2 | 2016 | 645 | 0.110 |
Why?
| | Accidents | 1 | 2014 | 40 | 0.110 |
Why?
| | Rats | 19 | 2002 | 5173 | 0.110 |
Why?
| | Intubation, Intratracheal | 1 | 2016 | 241 | 0.110 |
Why?
| | Needs Assessment | 1 | 2016 | 361 | 0.110 |
Why?
| | Child Advocacy | 1 | 2014 | 33 | 0.110 |
Why?
| | Nervous System Diseases | 1 | 1997 | 254 | 0.110 |
Why?
| | Craniotomy | 1 | 2014 | 70 | 0.110 |
Why?
| | Macrophages, Peritoneal | 2 | 2004 | 90 | 0.110 |
Why?
| | Radiography, Thoracic | 2 | 2013 | 164 | 0.110 |
Why?
| | Predictive Value of Tests | 4 | 2013 | 1943 | 0.110 |
Why?
| | Fluid Therapy | 1 | 2014 | 135 | 0.110 |
Why?
| | Contrast Media | 2 | 2015 | 388 | 0.110 |
Why?
| | Motor Skills | 1 | 2014 | 91 | 0.110 |
Why?
| | Embolization, Therapeutic | 1 | 2015 | 207 | 0.110 |
Why?
| | Pandemics | 1 | 2022 | 1491 | 0.110 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 127 | 0.110 |
Why?
| | Tracheotomy | 1 | 2013 | 24 | 0.110 |
Why?
| | Postoperative Complications | 6 | 2022 | 2496 | 0.110 |
Why?
| | Thrombophilia | 1 | 2013 | 66 | 0.110 |
Why?
| | Vascular Surgical Procedures | 2 | 2012 | 294 | 0.100 |
Why?
| | Urinalysis | 1 | 2013 | 72 | 0.100 |
Why?
| | Unnecessary Procedures | 1 | 2013 | 48 | 0.100 |
Why?
| | Coronary Disease | 1 | 1995 | 384 | 0.100 |
Why?
| | Blood Group Incompatibility | 1 | 2012 | 11 | 0.100 |
Why?
| | Interleukin-10 | 3 | 2004 | 299 | 0.100 |
Why?
| | Electroencephalography | 1 | 2015 | 396 | 0.100 |
Why?
| | Catheter-Related Infections | 1 | 2013 | 68 | 0.100 |
Why?
| | Forecasting | 1 | 2014 | 358 | 0.100 |
Why?
| | Television | 1 | 1993 | 74 | 0.100 |
Why?
| | Phenytoin | 1 | 2012 | 17 | 0.100 |
Why?
| | Abdominal Wound Closure Techniques | 1 | 2012 | 8 | 0.100 |
Why?
| | Piracetam | 1 | 2012 | 13 | 0.100 |
Why?
| | Angiography, Digital Subtraction | 1 | 2012 | 43 | 0.100 |
Why?
| | Patient Education as Topic | 1 | 2016 | 736 | 0.100 |
Why?
| | Orthopedic Procedures | 1 | 2014 | 228 | 0.090 |
Why?
| | Chemokines, CXC | 2 | 2002 | 68 | 0.090 |
Why?
| | Vasodilation | 4 | 1999 | 479 | 0.090 |
Why?
| | Surgical Procedures, Operative | 1 | 2014 | 246 | 0.090 |
Why?
| | Urinary Tract Infections | 1 | 2013 | 150 | 0.090 |
Why?
| | Rats, Sprague-Dawley | 10 | 2002 | 2245 | 0.090 |
Why?
| | Neutrophil Infiltration | 2 | 2002 | 103 | 0.090 |
Why?
| | Acute Disease | 6 | 2021 | 968 | 0.090 |
Why?
| | Thyroidectomy | 1 | 2011 | 88 | 0.090 |
Why?
| | Young Adult | 6 | 2022 | 12389 | 0.090 |
Why?
| | Fat Necrosis | 1 | 1990 | 7 | 0.090 |
Why?
| | Endocrinology | 1 | 2011 | 74 | 0.080 |
Why?
| | Myocardium | 4 | 1993 | 973 | 0.080 |
Why?
| | Cardiovascular Agents | 1 | 2011 | 152 | 0.080 |
Why?
| | Triamcinolone | 1 | 1989 | 15 | 0.080 |
Why?
| | Specialties, Surgical | 1 | 2011 | 78 | 0.080 |
Why?
| | Pericardium | 1 | 1990 | 54 | 0.080 |
Why?
| | Practice Guidelines as Topic | 2 | 2019 | 1493 | 0.080 |
Why?
| | Cerebrovascular Circulation | 1 | 2011 | 221 | 0.080 |
Why?
| | Anticonvulsants | 1 | 2012 | 198 | 0.080 |
Why?
| | Chest Pain | 1 | 1990 | 89 | 0.080 |
Why?
| | Diaphragm | 2 | 2004 | 43 | 0.080 |
Why?
| | Consensus | 2 | 2023 | 638 | 0.080 |
Why?
| | Oxygen | 2 | 1994 | 902 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1496 | 0.080 |
Why?
| | Perioperative Care | 1 | 2011 | 149 | 0.080 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2002 | 371 | 0.080 |
Why?
| | Suppuration | 1 | 2009 | 9 | 0.080 |
Why?
| | Aged | 7 | 2023 | 22083 | 0.080 |
Why?
| | Necrosis | 1 | 1990 | 231 | 0.080 |
Why?
| | General Surgery | 1 | 2011 | 157 | 0.080 |
Why?
| | Esophageal Stenosis | 1 | 1989 | 51 | 0.080 |
Why?
| | Biopsy | 1 | 1993 | 1086 | 0.080 |
Why?
| | Pulmonary Fibrosis | 1 | 1993 | 378 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2004 | 1192 | 0.080 |
Why?
| | Pediatrics | 2 | 2011 | 1062 | 0.080 |
Why?
| | Seizures | 1 | 2012 | 399 | 0.070 |
Why?
| | Asparaginase | 2 | 1998 | 29 | 0.070 |
Why?
| | Accidents, Traffic | 4 | 2011 | 187 | 0.070 |
Why?
| | Pulmonary Artery | 3 | 2000 | 1030 | 0.070 |
Why?
| | Aorta, Thoracic | 2 | 2021 | 261 | 0.070 |
Why?
| | Patient Discharge | 2 | 2016 | 857 | 0.070 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2005 | 174 | 0.070 |
Why?
| | Cyclic AMP | 2 | 2001 | 230 | 0.070 |
Why?
| | Pilot Projects | 1 | 2012 | 1567 | 0.070 |
Why?
| | Hernia, Inguinal | 2 | 1998 | 37 | 0.070 |
Why?
| | Pancreatitis | 2 | 1998 | 128 | 0.070 |
Why?
| | Middle Aged | 9 | 2016 | 31074 | 0.070 |
Why?
| | Biliary Atresia | 2 | 2000 | 160 | 0.070 |
Why?
| | Mediastinal Neoplasms | 1 | 2006 | 38 | 0.070 |
Why?
| | Endotoxemia | 3 | 2002 | 84 | 0.060 |
Why?
| | Hepatic Artery | 1 | 2006 | 58 | 0.060 |
Why?
| | Anti-Bacterial Agents | 1 | 2016 | 1671 | 0.060 |
Why?
| | Patient Care Team | 1 | 2011 | 602 | 0.060 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2006 | 37 | 0.060 |
Why?
| | Brachial Plexus | 1 | 2005 | 28 | 0.060 |
Why?
| | Signal Transduction | 2 | 2002 | 4838 | 0.060 |
Why?
| | Mediastinum | 1 | 2005 | 23 | 0.060 |
Why?
| | Kidney | 3 | 2004 | 1308 | 0.060 |
Why?
| | Nevus, Epithelioid and Spindle Cell | 1 | 2005 | 8 | 0.060 |
Why?
| | Rats, Inbred Strains | 8 | 1992 | 356 | 0.060 |
Why?
| | Neuroblastoma | 1 | 2006 | 154 | 0.060 |
Why?
| | Hospitals, Teaching | 1 | 2005 | 111 | 0.060 |
Why?
| | Cohort Studies | 1 | 2015 | 5407 | 0.060 |
Why?
| | Chemotactic Factors | 2 | 2002 | 54 | 0.060 |
Why?
| | Evidence-Based Medicine | 1 | 2009 | 718 | 0.060 |
Why?
| | Growth Substances | 2 | 2002 | 151 | 0.060 |
Why?
| | Renal Veins | 1 | 2004 | 15 | 0.060 |
Why?
| | Pulmonary Edema | 2 | 2002 | 104 | 0.060 |
Why?
| | Sentinel Lymph Node Biopsy | 1 | 2005 | 108 | 0.060 |
Why?
| | Heparin | 2 | 2019 | 240 | 0.060 |
Why?
| | Thoracic Surgical Procedures | 1 | 2005 | 69 | 0.060 |
Why?
| | Renal Artery | 1 | 2004 | 33 | 0.060 |
Why?
| | Leisure Activities | 1 | 2004 | 30 | 0.060 |
Why?
| | Physical Examination | 2 | 2014 | 236 | 0.060 |
Why?
| | Intestinal Perforation | 1 | 2004 | 44 | 0.060 |
Why?
| | Peroxidase | 7 | 2002 | 169 | 0.050 |
Why?
| | Granuloma, Plasma Cell | 1 | 2003 | 13 | 0.050 |
Why?
| | Hernia, Diaphragmatic | 1 | 2003 | 69 | 0.050 |
Why?
| | Pleural Effusion | 1 | 2003 | 49 | 0.050 |
Why?
| | Age Distribution | 5 | 2003 | 376 | 0.050 |
Why?
| | Twins, Conjoined | 1 | 2003 | 6 | 0.050 |
Why?
| | Animals | 23 | 2002 | 34600 | 0.050 |
Why?
| | Nephrectomy | 1 | 2004 | 159 | 0.050 |
Why?
| | Rib Fractures | 1 | 2003 | 32 | 0.050 |
Why?
| | Vital Signs | 1 | 2023 | 41 | 0.050 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2022 | 29 | 0.050 |
Why?
| | Fluoroscopy | 1 | 2003 | 158 | 0.050 |
Why?
| | Anal Canal | 1 | 2003 | 89 | 0.050 |
Why?
| | Solitary Pulmonary Nodule | 1 | 2002 | 20 | 0.050 |
Why?
| | Frail Elderly | 1 | 2023 | 120 | 0.050 |
Why?
| | Chemokine CXCL2 | 4 | 2002 | 43 | 0.050 |
Why?
| | Diseases in Twins | 1 | 2003 | 176 | 0.050 |
Why?
| | Peritonitis | 1 | 2002 | 80 | 0.050 |
Why?
| | Rectum | 1 | 2003 | 169 | 0.050 |
Why?
| | Receptors, Cell Surface | 2 | 2002 | 371 | 0.050 |
Why?
| | Comorbidity | 2 | 2023 | 1546 | 0.050 |
Why?
| | Patients | 1 | 2023 | 166 | 0.050 |
Why?
| | Abnormalities, Multiple | 1 | 2003 | 178 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2001 | 162 | 0.050 |
Why?
| | Inflammation Mediators | 1 | 2004 | 500 | 0.040 |
Why?
| | Receptors, Interleukin-1 | 1 | 2002 | 223 | 0.040 |
Why?
| | Pulmonary Circulation | 2 | 1999 | 416 | 0.040 |
Why?
| | Receptors, Chemokine | 1 | 2000 | 45 | 0.040 |
Why?
| | Drosophila Proteins | 1 | 2002 | 187 | 0.040 |
Why?
| | Joint Dislocations | 1 | 2000 | 65 | 0.040 |
Why?
| | Abbreviated Injury Scale | 1 | 2019 | 22 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2004 | 961 | 0.040 |
Why?
| | Surgical Wound Infection | 1 | 2023 | 282 | 0.040 |
Why?
| | Administrative Claims, Healthcare | 1 | 2019 | 27 | 0.040 |
Why?
| | Hydrogen Peroxide | 2 | 1992 | 308 | 0.040 |
Why?
| | Sex Distribution | 4 | 2002 | 359 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2002 | 466 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2023 | 7064 | 0.040 |
Why?
| | Arginine | 1 | 2001 | 259 | 0.040 |
Why?
| | Nitric Oxide Synthase | 1 | 2000 | 232 | 0.040 |
Why?
| | Cervical Vertebrae | 1 | 2000 | 135 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2019 | 110 | 0.040 |
Why?
| | Morbidity | 2 | 2014 | 302 | 0.040 |
Why?
| | Odds Ratio | 1 | 2022 | 1025 | 0.040 |
Why?
| | Antigens, CD | 1 | 2001 | 483 | 0.040 |
Why?
| | Salmonella typhi | 1 | 1998 | 13 | 0.040 |
Why?
| | Hernia, Femoral | 1 | 1998 | 4 | 0.040 |
Why?
| | Receptors, Adrenergic, alpha | 2 | 2000 | 25 | 0.040 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 1 | 1999 | 90 | 0.040 |
Why?
| | Edema | 1 | 1999 | 125 | 0.040 |
Why?
| | Monocytes | 1 | 2001 | 543 | 0.040 |
Why?
| | Monokines | 3 | 2002 | 22 | 0.040 |
Why?
| | Octreotide | 1 | 1998 | 24 | 0.040 |
Why?
| | Melanoma | 1 | 2005 | 752 | 0.040 |
Why?
| | Pneumonia | 1 | 2003 | 599 | 0.040 |
Why?
| | Skin Neoplasms | 1 | 2005 | 833 | 0.040 |
Why?
| | Platelet Aggregation Inhibitors | 2 | 2011 | 440 | 0.040 |
Why?
| | Cecal Diseases | 1 | 1997 | 3 | 0.040 |
Why?
| | Aorta | 1 | 2000 | 407 | 0.040 |
Why?
| | Analysis of Variance | 4 | 2004 | 1271 | 0.030 |
Why?
| | Perfusion | 3 | 1992 | 188 | 0.030 |
Why?
| | Survivors | 1 | 2020 | 463 | 0.030 |
Why?
| | Hospitals | 1 | 2021 | 632 | 0.030 |
Why?
| | Reoperation | 2 | 2012 | 560 | 0.030 |
Why?
| | Leukocyte Count | 2 | 2002 | 328 | 0.030 |
Why?
| | Aspirin | 1 | 2019 | 378 | 0.030 |
Why?
| | In Vitro Techniques | 3 | 1992 | 1044 | 0.030 |
Why?
| | Portoenterostomy, Hepatic | 1 | 1996 | 45 | 0.030 |
Why?
| | Abdominal Pain | 1 | 1997 | 148 | 0.030 |
Why?
| | Cystic Duct | 1 | 1996 | 4 | 0.030 |
Why?
| | Hepatic Duct, Common | 1 | 1996 | 6 | 0.030 |
Why?
| | Sepsis | 1 | 2002 | 557 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2016 | 193 | 0.030 |
Why?
| | Cholecystectomy, Laparoscopic | 1 | 1996 | 51 | 0.030 |
Why?
| | Recovery of Function | 2 | 2015 | 648 | 0.030 |
Why?
| | Ketone Bodies | 2 | 1992 | 14 | 0.030 |
Why?
| | Receptors, Purinergic P1 | 1 | 1994 | 22 | 0.030 |
Why?
| | Stomach Volvulus | 1 | 1994 | 1 | 0.030 |
Why?
| | Disease-Free Survival | 2 | 2006 | 656 | 0.030 |
Why?
| | Pneumothorax | 2 | 2005 | 40 | 0.030 |
Why?
| | Radiography | 3 | 2003 | 865 | 0.030 |
Why?
| | Ventricular Pressure | 1 | 1994 | 43 | 0.030 |
Why?
| | Tetralones | 1 | 1993 | 4 | 0.030 |
Why?
| | Adenylyl Cyclases | 1 | 1994 | 82 | 0.030 |
Why?
| | Administration, Oral | 1 | 2016 | 759 | 0.030 |
Why?
| | Myocardial Reperfusion | 1 | 1993 | 50 | 0.030 |
Why?
| | Cardiac Output | 1 | 1994 | 155 | 0.030 |
Why?
| | Thoracoscopes | 1 | 1993 | 2 | 0.030 |
Why?
| | Conversion to Open Surgery | 1 | 2013 | 15 | 0.030 |
Why?
| | Evaluation Studies as Topic | 1 | 1993 | 172 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2016 | 1209 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 2 | 1998 | 1945 | 0.030 |
Why?
| | NF-kappa B | 3 | 2001 | 652 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 1994 | 331 | 0.020 |
Why?
| | Oligopeptides | 2 | 1991 | 258 | 0.020 |
Why?
| | Acetoacetates | 1 | 1992 | 2 | 0.020 |
Why?
| | Surgical Sponges | 1 | 2012 | 4 | 0.020 |
Why?
| | Hydroxybutyrates | 1 | 1992 | 11 | 0.020 |
Why?
| | Cost Control | 1 | 2012 | 38 | 0.020 |
Why?
| | Myocardial Ischemia | 1 | 1993 | 249 | 0.020 |
Why?
| | Blood Coagulation | 1 | 2013 | 226 | 0.020 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2012 | 21 | 0.020 |
Why?
| | Vertebral Artery | 1 | 2011 | 26 | 0.020 |
Why?
| | Endovascular Procedures | 1 | 2016 | 304 | 0.020 |
Why?
| | Decision Trees | 1 | 2012 | 89 | 0.020 |
Why?
| | Carotid Artery Injuries | 1 | 2011 | 41 | 0.020 |
Why?
| | Fever | 1 | 2013 | 301 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2012 | 138 | 0.020 |
Why?
| | Chemokine CXCL1 | 2 | 2002 | 73 | 0.020 |
Why?
| | Lipid A | 1 | 1991 | 29 | 0.020 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 1991 | 34 | 0.020 |
Why?
| | Cytokines | 1 | 1999 | 1987 | 0.020 |
Why?
| | Thyroid Diseases | 1 | 2011 | 35 | 0.020 |
Why?
| | Angiography | 1 | 2011 | 192 | 0.020 |
Why?
| | Neoplastic Syndromes, Hereditary | 1 | 2011 | 38 | 0.020 |
Why?
| | Drug Costs | 1 | 2012 | 103 | 0.020 |
Why?
| | Hospitals, University | 1 | 2011 | 176 | 0.020 |
Why?
| | Enzyme Induction | 1 | 1990 | 89 | 0.020 |
Why?
| | Pelvic Bones | 1 | 1993 | 155 | 0.020 |
Why?
| | Pancreatic Elastase | 1 | 1990 | 59 | 0.020 |
Why?
| | Thyroid Nodule | 1 | 2011 | 55 | 0.020 |
Why?
| | Clinical Protocols | 1 | 2012 | 254 | 0.020 |
Why?
| | Antioxidants | 2 | 1991 | 543 | 0.020 |
Why?
| | Interdisciplinary Communication | 1 | 2011 | 187 | 0.020 |
Why?
| | RNA, Messenger | 3 | 2002 | 2676 | 0.020 |
Why?
| | Survival Analysis | 2 | 2003 | 1265 | 0.020 |
Why?
| | Cyclic GMP | 2 | 1999 | 85 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2002 | 2329 | 0.020 |
Why?
| | Growth Disorders | 1 | 1989 | 80 | 0.020 |
Why?
| | Reperfusion Injury | 1 | 1992 | 263 | 0.020 |
Why?
| | Fibrinolytic Agents | 1 | 2011 | 249 | 0.020 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 1991 | 206 | 0.020 |
Why?
| | Liver Diseases | 1 | 1992 | 285 | 0.020 |
Why?
| | Shock, Septic | 1 | 1991 | 206 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 582 | 0.020 |
Why?
| | Radiology | 1 | 2011 | 162 | 0.020 |
Why?
| | Medical Oncology | 1 | 2011 | 274 | 0.020 |
Why?
| | Glutathione | 1 | 1990 | 334 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2011 | 427 | 0.020 |
Why?
| | Fractures, Bone | 1 | 1993 | 419 | 0.020 |
Why?
| | Thyroid Neoplasms | 1 | 2011 | 311 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 1998 | 2060 | 0.020 |
Why?
| | Intestinal Mucosa | 1 | 1992 | 579 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 1990 | 1002 | 0.020 |
Why?
| | Enzyme Inhibitors | 2 | 2000 | 811 | 0.020 |
Why?
| | Serum Albumin | 3 | 1992 | 145 | 0.020 |
Why?
| | Tissue Adhesions | 1 | 2006 | 31 | 0.020 |
Why?
| | Equipment Failure | 1 | 2006 | 109 | 0.020 |
Why?
| | Arm | 1 | 2005 | 110 | 0.010 |
Why?
| | Hypertension, Renovascular | 1 | 2004 | 13 | 0.010 |
Why?
| | Posture | 1 | 2005 | 176 | 0.010 |
Why?
| | Hydrocephalus | 1 | 2006 | 108 | 0.010 |
Why?
| | Lymphatic Metastasis | 1 | 2005 | 318 | 0.010 |
Why?
| | Subclavian Vein | 1 | 2003 | 14 | 0.010 |
Why?
| | Hemothorax | 1 | 2003 | 11 | 0.010 |
Why?
| | Rupture | 1 | 2004 | 100 | 0.010 |
Why?
| | Abdominal Abscess | 1 | 2003 | 26 | 0.010 |
Why?
| | Rectovaginal Fistula | 1 | 2003 | 9 | 0.010 |
Why?
| | Jugular Veins | 1 | 2003 | 39 | 0.010 |
Why?
| | Appendix | 1 | 2003 | 27 | 0.010 |
Why?
| | Fetal Death | 1 | 2003 | 56 | 0.010 |
Why?
| | Gene Expression Regulation | 2 | 2004 | 2508 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 2006 | 1293 | 0.010 |
Why?
| | Zymosan | 1 | 2002 | 65 | 0.010 |
Why?
| | Creatinine | 1 | 2004 | 475 | 0.010 |
Why?
| | Renal Insufficiency | 1 | 2004 | 148 | 0.010 |
Why?
| | Safety | 1 | 2004 | 329 | 0.010 |
Why?
| | Medical Errors | 1 | 2003 | 104 | 0.010 |
Why?
| | Diagnostic Errors | 1 | 2003 | 160 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2001 | 42 | 0.010 |
Why?
| | Probability | 1 | 2002 | 308 | 0.010 |
Why?
| | Biopsy, Needle | 1 | 2002 | 189 | 0.010 |
Why?
| | Mice, Inbred C3H | 1 | 2002 | 274 | 0.010 |
Why?
| | Bucladesine | 1 | 2001 | 24 | 0.010 |
Why?
| | Catalase | 2 | 1992 | 122 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2001 | 83 | 0.010 |
Why?
| | Toll-Like Receptor 2 | 1 | 2002 | 110 | 0.010 |
Why?
| | Vinblastine | 2 | 1992 | 68 | 0.010 |
Why?
| | Sialoglycoproteins | 1 | 2002 | 152 | 0.010 |
Why?
| | Spine | 1 | 2003 | 159 | 0.010 |
Why?
| | Toll-Like Receptors | 1 | 2002 | 179 | 0.010 |
Why?
| | Vagina | 1 | 2003 | 176 | 0.010 |
Why?
| | Nitrites | 1 | 2001 | 81 | 0.010 |
Why?
| | I-kappa B Proteins | 1 | 2001 | 73 | 0.010 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 250 | 0.010 |
Why?
| | Nitrates | 1 | 2001 | 87 | 0.010 |
Why?
| | Trachea | 1 | 2002 | 221 | 0.010 |
Why?
| | omega-N-Methylarginine | 1 | 2000 | 26 | 0.010 |
Why?
| | Guanidines | 1 | 2000 | 36 | 0.010 |
Why?
| | Renal Dialysis | 1 | 2004 | 420 | 0.010 |
Why?
| | Recurrence | 1 | 2003 | 1003 | 0.010 |
Why?
| | I-kappa B Kinase | 1 | 2000 | 53 | 0.010 |
Why?
| | Mice | 3 | 2002 | 16644 | 0.010 |
Why?
| | Arteriosclerosis | 1 | 2000 | 88 | 0.010 |
Why?
| | Interleukin-6 | 1 | 2004 | 718 | 0.010 |
Why?
| | Toll-Like Receptor 4 | 1 | 2002 | 263 | 0.010 |
Why?
| | Animals, Newborn | 1 | 2002 | 805 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 816 | 0.010 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2000 | 167 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2000 | 291 | 0.010 |
Why?
| | Immunoblotting | 1 | 2000 | 300 | 0.010 |
Why?
| | Pulmonary Alveoli | 1 | 2002 | 366 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2002 | 627 | 0.010 |
Why?
| | Fluorescent Antibody Technique | 1 | 2000 | 374 | 0.010 |
Why?
| | Antibodies | 1 | 2001 | 391 | 0.010 |
Why?
| | Niacinamide | 1 | 1999 | 73 | 0.010 |
Why?
| | Histamine Agonists | 1 | 1998 | 1 | 0.010 |
Why?
| | Dimaprit | 1 | 1998 | 3 | 0.010 |
Why?
| | Prevalence | 1 | 2005 | 2564 | 0.010 |
Why?
| | Blood Circulation | 1 | 1998 | 40 | 0.010 |
Why?
| | Benzamides | 1 | 1999 | 195 | 0.010 |
Why?
| | Vas Deferens | 1 | 1998 | 12 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2002 | 1284 | 0.010 |
Why?
| | Escherichia coli | 1 | 2002 | 771 | 0.010 |
Why?
| | Adrenergic beta-Agonists | 1 | 1998 | 129 | 0.010 |
Why?
| | Placebo Effect | 1 | 1997 | 56 | 0.010 |
Why?
| | Vascular Resistance | 1 | 1998 | 369 | 0.010 |
Why?
| | Sex Factors | 1 | 2003 | 1953 | 0.010 |
Why?
| | Cell Movement | 1 | 2001 | 939 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1999 | 471 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2000 | 421 | 0.010 |
Why?
| | Energy Metabolism | 2 | 1993 | 836 | 0.010 |
Why?
| | Intraoperative Period | 1 | 1996 | 53 | 0.010 |
Why?
| | Hospital Costs | 1 | 1997 | 117 | 0.010 |
Why?
| | Graft Rejection | 1 | 2000 | 558 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2004 | 4010 | 0.010 |
Why?
| | Iothalamate Meglumine | 1 | 1996 | 4 | 0.010 |
Why?
| | Cholangiography | 1 | 1996 | 17 | 0.010 |
Why?
| | Gene Expression | 1 | 2001 | 1462 | 0.010 |
Why?
| | Gallbladder | 1 | 1996 | 17 | 0.010 |
Why?
| | Traction | 1 | 1996 | 18 | 0.010 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2000 | 312 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2000 | 1000 | 0.010 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 1996 | 65 | 0.010 |
Why?
| | Disabled Persons | 1 | 1997 | 140 | 0.010 |
Why?
| | Dissection | 1 | 1996 | 56 | 0.010 |
Why?
| | Single-Blind Method | 1 | 1996 | 269 | 0.010 |
Why?
| | DNA | 1 | 2001 | 1392 | 0.010 |
Why?
| | Phenethylamines | 1 | 1993 | 23 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2000 | 2765 | 0.010 |
Why?
| | Adenosine | 1 | 1994 | 211 | 0.010 |
Why?
| | Norepinephrine | 1 | 1993 | 209 | 0.010 |
Why?
| | Ibuprofen | 1 | 1992 | 80 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2002 | 3953 | 0.010 |
Why?
| | Nitroblue Tetrazolium | 1 | 1991 | 12 | 0.010 |
Why?
| | Ventricular Function | 1 | 1991 | 60 | 0.010 |
Why?
| | Tungsten | 1 | 1991 | 30 | 0.010 |
Why?
| | Arrhythmias, Cardiac | 1 | 1993 | 317 | 0.010 |
Why?
| | Chemotaxis, Leukocyte | 1 | 1991 | 136 | 0.010 |
Why?
| | Staining and Labeling | 1 | 1991 | 139 | 0.010 |
Why?
| | Azepines | 1 | 1991 | 88 | 0.010 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 1 | 1990 | 54 | 0.010 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 1990 | 24 | 0.010 |
Why?
| | Permeability | 1 | 1991 | 156 | 0.010 |
Why?
| | Endothelium | 1 | 1991 | 107 | 0.010 |
Why?
| | Triazoles | 1 | 1991 | 152 | 0.010 |
Why?
| | Cell Adhesion | 1 | 1991 | 445 | 0.010 |
Why?
| | Liver Transplantation | 1 | 1996 | 799 | 0.000 |
Why?
| | Kinetics | 1 | 1992 | 1617 | 0.000 |
Why?
| | Biomechanical Phenomena | 1 | 1990 | 780 | 0.000 |
Why?
| | Proteins | 1 | 1991 | 936 | 0.000 |
Why?
| | Diet | 1 | 1991 | 1204 | 0.000 |
Why?
|
|
Bensard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|